登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，6月15日，Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-06-16

  • Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

    Deborah Steensels, PharmD, PhD1; Els Oris, MD1; Laura Coninx, MSc, PhD1; et al Dieter Nuyens, MD, PhD1; Marie-Luce Delforge, MD, PhD2; Pieter Vermeersch, MD, PhD3; Line Heylen, MD, PhD1,4

    Author Affiliations Article Information

    JAMA. Published online June 15, 2020. doi:10.1001/jama.2020.11160

    Belgium has a high burden of coronavirus disease 2019 (COVID-19), especially the region surrounding the Hospital East-Limburg, a tertiary care center.1 Infection prevention measures were instituted in the hospital beginning March 4, 2020, including testing and contact tracing of all symptomatic patients and staff, changes in hospital operations, and provision of personal protective equipment (PPE). The first case was detected March 13 (Figure 1). We investigated the prevalence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among hospital staff.

  • 原文来源：https://jamanetwork.com/journals/jama/fullarticle/2767382?resultClick=1
37浏览量
原文链接
相关报告

  • 《6月15日_比利时东林堡总医院3056名员工SARS-CoV-2抗体筛查结果分析》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-06-19
    • 信息名称：比利时东林堡总医院3056名员工SARS-CoV-2抗体筛查结果分析 1.时间：2020年6月15日 2.机构或团队：比利时东林堡总医院、布鲁塞尔自由大学、鲁汶大学医院、哈瑟尔特大学 3.事件概要： 比利时东林堡总医院等于6月15日在JAMA上发表题为“Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium”的文章，调查了比利时东林堡总医院工作人员中SARS-CoV-2抗体的情况。文章指出，2020年4月22日至2020年4月30日，对该医院的所有工作人员（包括临床和非临床工作人员及志愿者）进行血清学检测；有症状的工作人员被隔离，不进行检测。文章结果显示，该医院4125名员工中有3056人参与检测；在没有接受检测的人员中，至少有三分之一是在此期间没有上班的人员；共检测到197名员工有SARS-CoV-2的IgG抗体；年龄和性别在有无抗体的员工中没有显著的统计学差异；参与临床护理、在封锁期间工作过、参与过COVID-19患者的护理以及接触过COVID-19阳性同事的情况与血清阳性率无统计学相关；相反，接触疑似或确诊的COVID-19家庭成员与抗体阳性率相关。作者指出，该研究显示，直接参与临床护理或在COVID-19诊疗科室工作都不会增加血清阳性的几率，而有疑似COVID-19家庭接触者则会增加几率。个人防护用品的高可用性、高标准的感染预防措施、对有症状工作人员的PCR筛查，以及接触者追踪和隔离，可能是血清阳性率相对较低的原因。 4.附件： 原文链接： https://jamanetwork.com/journals/jama/fullarticle/2767382?resultClick=1
    192浏览量
    原文链接

  • 《JAMA，3月25日，SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-26
    • SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China Jing Yu, MD1,2,3; Wen Ouyang, MD1,2,3; Melvin L. K. Chua, MBBS, PhD1,4,5; et alConghua Xie, MD1,2,3 Author Affiliations Article Information JAMA Oncol. Published online March 25, 2020. doi:10.1001/jamaoncol.2020.0980 In December 2019, an outbreak of 2019 novel coronavirus disease (COVID-19) occurred in Wuhan, Hubei, which has been linked to the severe adult respiratory syndrome coronavirus 2 (SARS-CoV-2). It is characterized by rapid human-to-human transmission from droplet contamination.1,2 A report of 138 hospitalized patients from a single institution (Zhongnan Hospital of Wuhan University) indicated that hospital-acquired transmission accounted for 41.3% of these admitted patients, thus implicating the hospital environment as a source of spread of the virus.3 Patients with cancer are often recalled to the hospital for treatment and monitoring, and hence, they may be at risk of contracting COVID-19. Moreover, cancer treatments such as chemotherapy and radiotherapy are immunosuppressive. Here, we report the incidence and outcomes of SARS-CoV-2 infection in cancer patients who were treated at a tertiary cancer institution in Wuhan.
    35浏览量
    原文链接